ZYNE - 3 Reasons Biotech Should Rally In 2019
If lies are more comforting to you than facts, you need to get out of your comfort zone.”
- DaShanne Stokes
Biotech seems to be off to a good start to begin 2019. After early losses on Thursday, the sector reversed and ended the day up one and half percent. The January effect seem to hit some oversold small caps on Monday, which helped names like Conatus Pharmaceuticals (CNAT) and Axsome Therapeutics (AXSM) rise by more than 20% on the day.
The market was closed on Tuesday. Wednesday, we saw